SPAZ reduced maternal parasitaemia ( RR : 0.57 , 95 % CI : 0.35-0 .95 , P = 0.029 ) and active placental malaria ( 0.68 , 95 % CI : 0.47-0 .98 , P = 0.037 ) , and reduced carriage of gonorrhoea ( 0.66 , 95 % CI : 0.44-0 .99 , P = 0.041 ) at second visit .